Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02366299

Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS.

Comparison of Sedative Effects of Dexmedetomidine and Propofol on the Clinical Course of Delirium and Neuroinflammation in Patients With SIRS.

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Moscow Regional Research and Clinical Institute (MONIKI) · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Assessment of sedative effects of dexmedetomidine and propofol on the clinical course of delirium and neuroinflammation in patients with SIRS using CAM-ICU scale and protein S100b in serum.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineTreatment of delirium by dexmedetomidine i.v. infusion
DRUGPropofolTreatment of delirium by Propofol i.v. infusion

Timeline

Start date
2015-02-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2015-02-19
Last updated
2019-08-14

Source: ClinicalTrials.gov record NCT02366299. Inclusion in this directory is not an endorsement.